An integer programming approach for optimal drug dose computation
暂无分享,去创建一个
[1] Malcolm Rowland,et al. Hepatic clearance of drugs. I. Theoretical considerations of a “well-stirred” model and a “parallel tube” model. Influence of hepatic blood flow, plasma and blood cell binding, and the hepatocellular enzymatic activity on hepatic drug clearance , 1977, Journal of Pharmacokinetics and Biopharmaceutics.
[2] Michael Nikolaou,et al. FIR model identification: Parsimony through kernel compression with wavelets , 1998 .
[3] Thomas J. McAvoy,et al. Nonlinear FIR Modeling via a Neural Net PLS Approach , 1996 .
[4] A Schumitzky,et al. Design of dosage regimens: a multiple model stochastic control approach. , 1994, International journal of bio-medical computing.
[5] W. Lovejoy,et al. An efficient control strategy for dosage regimens , 1994, Journal of Pharmacokinetics and Biopharmaceutics.
[6] E. Lee,et al. Weighted target interval stochastic control methods with global optimization and their applications in individualizing therapy , 2007, Journal of Pharmacokinetics and Pharmacodynamics.
[7] Panos M. Pardalos,et al. Modeling and integer programming techniques applied to propositional calculus , 1990, Comput. Oper. Res..
[8] Jan M. Maciejowski,et al. Predictive control : with constraints , 2002 .
[9] Younggil Kwon,et al. Handbook of Essential Pharmacokinetics, Pharmacodynamics and Drug Metabolism for Industrial Scientists , 2001, Springer US.
[10] Pantelis Sopasakis,et al. A Model Predictive Control Approach for Optimal Drug Administration , 2009 .
[11] Dimitri P. Bertsekas,et al. Dynamic Programming and Optimal Control, Vol. II , 1976 .
[12] R. Ocampo-Pérez,et al. Adsorption of Fluoride from Water Solution on Bone Char , 2007 .
[13] Alberto Bemporad,et al. Control of systems integrating logic, dynamics, and constraints , 1999, Autom..
[14] Selection of optimal dose. , 1985, Computers and biomedical research, an international journal.
[15] J. Macgregor,et al. Identification of finite impulse response models : Methods and robustness issues , 1996 .
[16] Efstratios N. Pistikopoulos,et al. Global Optimization Issues in Multiparametric Continuous and Mixed-Integer Optimization Problems , 2004, J. Glob. Optim..
[17] C Kulcsár,et al. Optimal experimental design and therapeutic drug monitoring. , 1994, International journal of bio-medical computing.
[18] D Bayard,et al. Achieving target goals most precisely using nonparametric compartmental models and "multiple model" design of dosage regimens. , 2000, Therapeutic drug monitoring.
[19] J. Au,et al. Physiologically Based Pharmacokinetic Models of 2′,3′-Dideoxyinosine , 1997, Pharmaceutical Research.
[20] S S Hacisalihzade,et al. Solution of the multiple dosing problem using linear programming. , 1985, International journal of bio-medical computing.
[21] Paolo Zunino,et al. Multidimensional Pharmacokinetic Models Applied to the Design of Drug-Eluting Stents , 2004 .
[22] Dimitri P. Bertsekas,et al. Dynamic Programming and Optimal Control, Two Volume Set , 1995 .
[23] S S Hacisalihzade,et al. A simple algorithm for the solution of the multiple dosing problem. , 1985, Computer methods and programs in biomedicine.
[24] K. Black,et al. Intravenous levodopa administration in humans based on a two-compartment kinetic model , 2007, Journal of Neuroscience Methods.
[25] J. Hardman,et al. Factors affecting drug absorption and distribution , 2008 .
[26] Jacek M. Zurada,et al. Individualization of pharmacological anemia management using reinforcement learning , 2005, Neural Networks.
[27] Lennart Ljung,et al. Linear approximations of nonlinear FIR systems for separable input processes , 2005, Autom..
[28] K. Itoh,et al. Factors Affecting the Pharmacokinetics of CPT-11: The Body Mass Index, Age and Sex are Independent Predictors of Pharmacokinetic Parameters of CPT-11 , 2004, Investigational New Drugs.
[29] Richard Magin,et al. Fractional kinetics in multi-compartmental systems , 2010, Journal of Pharmacokinetics and Pharmacodynamics.
[30] J. Doull,et al. Dose and time as variables of toxicity. , 2000, Toxicology.
[31] M. Nomoto,et al. Pharmacokinetics of l-dopa in plasma and extracellular fluid of striatum in common marmosets , 2003, Brain Research.
[32] L Aarons,et al. Population pharmacokinetics: theory and practice. , 1991, British journal of clinical pharmacology.
[33] J. Rodman,et al. Targeting the systemic exposure of teniposide in the population and the individual using a stochastic therapeutic objective , 1993, Journal of Pharmacokinetics and Biopharmaceutics.
[34] P. Hansen,et al. Essays and surveys in global optimization , 2005 .
[35] V. A. Roshchin,et al. Models and methods of solution of quadratic integer programming problems , 1987 .